Summary
- Current Price
- As of today, VVOS price is $0.34, up +12.45% on
- Current Price All-Time High
- VVOS price is currently -99.90% below its historical high of $360.25 set on
- Market Cap
- VVOS current market cap is $5M, down -85.87% year-over-year
- Revenue
- VVOS current annual revenue is $17.44M, up +16.05% year-over-year
- Next Earnings
- The next earnings release for VVOS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Vivos Therapeutics, Inc. |
| Ticker | NASDAQ: VVOS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vivos.com |
| Employees | 113 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.34 | ||
| Price, 1D Change | +12.45% | |
| $5M | ||
| - | ||
| - | ||
| 0.90 | ||
| $17.44M | ||
| Revenue, 1Y Change | +16.05% | |
| -$2.06 | ||
| EPS, 1Y Change | +7.11% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.06 | ||
| EPS Estimate | -$1.39 | N/A |
| EPS Est. Change | +32.42% | N/A |
| $17.44M | ||
| Revenue Estimate | $24.06M | N/A |
| Revenue Est. Change | +37.91% | N/A |
| $0.34 | ||
| Price Target | $2.50 | - |
| Price Tgt. Change | +628.23% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.79 | -$2.22 | -23.93% | |
| -$2.03 | -$2.06 | -1.67% | |
| -$1.39 | N/A | +32.42% | |
| -$0.79 | N/A | +61.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.20M | $15.03M | -1.12% | |
| $20.71M | $17.44M | -15.77% | |
| $24.06M | N/A | +37.91% | |
| $34.09M | N/A | +95.43% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -92.55% | ||
| -96.00% | ||
| -85.87% | ||
| -53.54% | ||
| +16.05% | ||
| +8.86% | ||
| +7.11% | ||
| +92.05% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.34 | ||
| $1.30 | ||
| $0.46 | ||
| $1.30 | ||
| $0.48 | ||
| -$0.04 | ||
| 0.90 | ||
| $0.05 | ||
| 41.63 | ||
| 175.16% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $17.44M | ||
| -$2.06 | ||
| $9.23M | ||
| 52.93% | ||
| -$19.89M | ||
| -114.05% | ||
| -$21.23M | ||
| -121.71% | ||
| -$18.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -9.06 | ||
| 0.24 | ||
| 0.24 | ||
| - | ||
| 2 | ||
| -9.44 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 0.24 | ||
| -4.19 | ||
| -0.71 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$1.49M | ||
| $2.03M | ||
| $25.15M | ||
| $4.38M | ||
| $26.70M | ||
| $18.08M | ||
| $13.50M | ||
| $9.08M | ||
| $1.68M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $38.61M | ||
| $29.13M | ||
| $8.21M | ||
| $0.00 | ||
| $1.31M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$15.26M | ||
| -$7.53M | ||
| $18.56M | ||
| $2.34M | ||
| -$17.60M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | ||
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Alliance Global Partners | → | |
| Ascendiant Capital | → |
Analyst sentiment
Institutional ownership
Screeners with VVOS
FAQ
- What is the ticker symbol for Vivos Therapeutics, Inc.?
- The ticker symbol for Vivos Therapeutics, Inc. is NASDAQ:VVOS
- Does Vivos Therapeutics, Inc. pay dividends?
- No, Vivos Therapeutics, Inc. does not pay dividends
- What sector is Vivos Therapeutics, Inc. in?
- Vivos Therapeutics, Inc. is in the Healthcare sector
- What industry is Vivos Therapeutics, Inc. in?
- Vivos Therapeutics, Inc. is in the Medical Devices industry
- What country is Vivos Therapeutics, Inc. based in?
- Vivos Therapeutics, Inc. is headquartered in United States
- When did Vivos Therapeutics, Inc. go public?
- Vivos Therapeutics, Inc. initial public offering (IPO) was on December 11, 2020
- Is Vivos Therapeutics, Inc. in the S&P 500?
- No, Vivos Therapeutics, Inc. is not included in the S&P 500 index
- Is Vivos Therapeutics, Inc. in the NASDAQ 100?
- No, Vivos Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Vivos Therapeutics, Inc. in the Dow Jones?
- No, Vivos Therapeutics, Inc. is not included in the Dow Jones index
- When was Vivos Therapeutics, Inc. last earnings report?
- Vivos Therapeutics, Inc.'s most recent earnings report was on May 22, 2026
- When does Vivos Therapeutics, Inc. report earnings?
- The next expected earnings date for Vivos Therapeutics, Inc. is August 14, 2026
Data Sources & References
- VVOS Official Website www.vivos.com
- VVOS Profile on Yahoo Finance finance.yahoo.com/quote/VVOS
- VVOS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vvos